224 related articles for article (PubMed ID: 19469177)
1. [Prophylaxsis against recurrance of hepatitis B virus after liver transplantation].
Wu JS; Lu SC; Wang ML; Xia RP; Guo QL; Gao DM; Zhang Y; Liu Y; Li N
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Oct; 22(5):367-9. PubMed ID: 19469177
[TBL] [Abstract][Full Text] [Related]
2. [Post-transplant prophylaxis of the recurrence of lamivudine-resistant YMDD mutant hepatitis B virus in liver recipients].
Yang Y; Yang Y; Zhang J; Yi HM; Lu MQ; Cai CJ; Li X; Jiang N; Xu C; Li H; Wang GS; Yi SH; Zhang JF; Jiang H; Yang Q; Chen GH
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1810-2. PubMed ID: 18971179
[TBL] [Abstract][Full Text] [Related]
3. [Prevention and management of hepatitis B virus reinfection after liver transplantation].
Ma Y; Tai Q; He XS; Wang GD; Hu AB
Zhonghua Wai Ke Za Zhi; 2009 Aug; 47(16):1209-12. PubMed ID: 19781163
[TBL] [Abstract][Full Text] [Related]
4. [Prevention and treatment of hepatitis B virus reinfection after liver transplantation].
Liu J; Wu GC; Zhang ZT; Wu P; Zhang D; Sun MC; Gao DC; Wang Y; Jia JD; Wang BE
Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):976-9. PubMed ID: 16194352
[TBL] [Abstract][Full Text] [Related]
5. Advances in prophylaxis and treatment of recurrent hepatitis B after liver transplantation.
Wang ZF; Zhu ZJ; Shen ZY
Hepatobiliary Pancreat Dis Int; 2005 Nov; 4(4):509-14. PubMed ID: 16286253
[TBL] [Abstract][Full Text] [Related]
6. Role of long-term lamivudine treatment of hepatitis B virus recurrence after liver transplantation.
Woo HY; Choi JY; Jang JW; You CR; Bae SH; Yoon SK; Yang JM; Choi SW; Han NI; Kim DG
J Med Virol; 2008 Nov; 80(11):1891-9. PubMed ID: 18814257
[TBL] [Abstract][Full Text] [Related]
7. Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation.
Lu SC; Yan LN; Li B; Wen TF; Zhao JC; Cheng NS; Liu C; Liu J; Wang XB; Li XD; Qin S; Zhao LS; Lei BJ; Zhang XH
Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):26-32. PubMed ID: 14969833
[TBL] [Abstract][Full Text] [Related]
8. No hepatitis recurrence using combination prophylaxis in HBV-positive liver transplant recipients with YMDD mutants.
Caccamo L; Romeo R; Rossi G; Maggioni M; Radice F; Lunghi G; Colombo M; Fassati LR
Transpl Int; 2005 Feb; 18(2):186-92. PubMed ID: 15691271
[TBL] [Abstract][Full Text] [Related]
9. Low-dose intramuscular hepatitis B immune globulin and lamivudine for long-term prophylaxis of hepatitis B recurrence after liver transplantation.
Ferretti G; Merli M; Ginanni Corradini S; Callejon V; Tanzilli P; Masini A; Ferretti S; Iappelli M; Rossi M; Rivanera D; Lilli D; Mancini C; Attili A; Berloco P
Transplant Proc; 2004 Apr; 36(3):535-8. PubMed ID: 15110584
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of hepatitis B virus recurrence after liver transplantation.
Han YS; Lee SK; Joh JW; Kim SJ; Kwon CH; Park JW; Kim DJ; Park JB
Transplant Proc; 2006 Sep; 38(7):2123-4. PubMed ID: 16980019
[TBL] [Abstract][Full Text] [Related]
11. [Prevention and treatment of hepatitis B virus reinfection after liver transplantation].
Lu MQ; Cai CJ; Zhao H; Yang Y; Chen GH
Zhonghua Wai Ke Za Zhi; 2006 Jun; 44(11):742-4. PubMed ID: 16836920
[TBL] [Abstract][Full Text] [Related]
12. Lamivudine monoprophylaxis for liver transplant recipients with non-replicating hepatitis B virus infection.
Yoshida H; Kato T; Levi DM; Regev A; Madariaga JR; Nishida S; Martinez EJ; Schiff ER; Omata M; Tzakis AG
Clin Transplant; 2007; 21(2):166-71. PubMed ID: 17425740
[TBL] [Abstract][Full Text] [Related]
13. Living donor liver transplantation for hepatitis B associated liver diseases: a 10-year experience in a single center.
Ikegami T; Soejima Y; Ohta R; Taketomi A; Yoshizumi T; Harada N; Kayashima H; Maehara Y
Hepatogastroenterology; 2008; 55(85):1445-9. PubMed ID: 18795708
[TBL] [Abstract][Full Text] [Related]
14. Safe use of livers from donors with positive hepatitis B core antibody.
Manzarbeitia C; Reich DJ; Ortiz JA; Rothstein KD; Araya VR; Munoz SJ
Liver Transpl; 2002 Jun; 8(6):556-61. PubMed ID: 12037788
[TBL] [Abstract][Full Text] [Related]
15. Lamivudine prophylaxis reduces the incidence and severity of hepatitis in hepatitis B virus carriers who receive chemotherapy for lymphoma.
Li YH; He YF; Jiang WQ; Wang FH; Lin XB; Zhang L; Xia ZJ; Sun XF; Huang HQ; Lin TY; He YJ; Guan ZZ
Cancer; 2006 Mar; 106(6):1320-5. PubMed ID: 16470607
[TBL] [Abstract][Full Text] [Related]
16. The incidence and clinical outcome of YMDD mutants in hepatitis B surface antigen-positive renal allograft recipients after prolonged lamivudine therapy.
Gwak GY; Huh W; Lee DH; Choi MS; Lee JH; Koh KC; Kim SJ; Joh JW; Oh HY
Transplant Proc; 2007 Dec; 39(10):3121-6. PubMed ID: 18089336
[TBL] [Abstract][Full Text] [Related]
17. Lamivudine for the prevention of hepatitis B virus reactivation after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with advanced or relapsed non-Hodgkin's lymphoma single institution experience.
Huang H; Cai Q; Lin T; Lin X; Liu Y; Gao Y; Peng R
Expert Opin Pharmacother; 2009 Oct; 10(15):2399-406. PubMed ID: 19761353
[TBL] [Abstract][Full Text] [Related]
18. Liver transplantation for hepatitis B-induced liver disease: long-term outcome and effectiveness of antiviral therapy for prevention of recurrent hepatitis B infection.
Perrakis A; Förtsch T; Del Medico A; Croner RS; Vassos N; Yedibela S; Lohmüller C; Zopf S; Hohenberger W; Müller V
Transplant Proc; 2013 Jun; 45(5):1953-6. PubMed ID: 23769081
[TBL] [Abstract][Full Text] [Related]
19. Management of hepatitis B in liver transplant recipients.
Coffin CS; Terrault NA
J Viral Hepat; 2007 Nov; 14 Suppl 1():37-44. PubMed ID: 17958641
[TBL] [Abstract][Full Text] [Related]
20. Prophylaxis of recurrent hepatitis B in Chinese patients after liver transplantation using lamivudine combined with hepatitis B immune globulin according to the titer of antibody to hepatitis B surface antigen.
Jiao ZY; Jiao Z
Transplant Proc; 2007 Jun; 39(5):1533-6. PubMed ID: 17580182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
